Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001429260-26-000002
Filing Date
2026-01-05
Accepted
2026-01-05 16:30:31
Documents
1
Period of Report
2026-01-02

Document Format Files

Seq Description Document Type Size
1 form4-01052026_040122.html 4  
1 form4-01052026_040122.xml 4 3491
  Complete submission text file 0001429260-26-000002.txt   5325
Mailing Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154
Business Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154 781-652-4500
Fortress Biotech, Inc. (Reporting) CIK: 0001429260 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38191 | Film No.: 26506800
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 95 SAWYER RD SUITE 110 WALTHAM MA 02453
Business Address 95 SAWYER RD SUITE 110 WALTHAM MA 02453 7816524500
MUSTANG BIO, INC. (Issuer) CIK: 0001680048 (see all company filings)

EIN.: 473828760 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)